Clinical trials
Terminated Stroke trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
161 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 8 |
| 2006 | 5 |
| 2007 | 5 |
| 2008 | 4 |
| 2009 | 6 |
| 2010 | 2 |
| 2011 | 6 |
| 2012 | 13 |
| 2013 | 9 |
| 2014 | 11 |
| 2015 | 5 |
| 2016 | 6 |
| 2017 | 14 |
| 2018 | 12 |
| 2019 | 17 |
| 2020 | 7 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 161 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Columbia University | 7 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 4 |
| Spaulding Rehabilitation Hospital | 4 |
| University of California, Los Angeles | 4 |
| University of Pittsburgh | 4 |
| Emory University | 3 |
| Johns Hopkins University | 3 |
| Mayo Clinic | 3 |
| Northwell Health | 3 |
| Pfizer | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stroke | 161 |
| Ischemic Stroke | 22 |
| Paresis | 8 |
| Brain Ischemia | 7 |
| Cardiovascular Diseases | 7 |
| Ischemic Attack, Transient | 7 |
| Muscle Spasticity | 7 |
| Atherosclerosis | 5 |
| Cerebrovascular Disorders | 5 |
| Hemiplegia | 5 |
Trials
Showing 1 to 25 of 161. Each trial links to its page on Pharma Observatory.
61 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.